📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Loading analysis...
CRISIL Reaffirms Meghmani Organics Rating at 'A', Revises Outlook to 'Negative'
CRISIL Ratings has reaffirmed the long-term rating of Meghmani Organics Limited at 'CRISIL A' but has revised the outlook from 'Stable' to 'Negative'. The short-term rating remains reaffirmed at 'CRISIL A1' for bank facilities totaling Rs. 1,094 crore. A 'Negative' outlook indicates that the rating may be downgraded in the future if the company's financial or operational performance remains under pressure. This review covers a wide range of fund-based and non-fund-based facilities across multiple major banks.
Key Highlights
CRISIL reaffirmed the long-term rating at 'CRISIL A' but revised the outlook to 'Negative' from 'Stable'.
Short-term rating reaffirmed at 'CRISIL A1' for total bank facilities of Rs. 1,094 crore.
The rating covers 19 specific bank facility classes, including a Rs. 250 crore cash credit from State Bank of India.
Major exposures include ICICI Bank (Rs. 115 crore) and HDFC Bank (Rs. 95 crore) across various limits.
The outlook revision suggests potential concerns regarding the company's credit profile or debt-servicing ability in the medium term.
💼 Action for Investors
Investors should exercise caution as the 'Negative' outlook suggests a potential credit downgrade if financial metrics do not improve. Monitor the company's debt levels and interest coverage ratios in upcoming quarterly reports.
Loading analysis...
Mold-Tek Technologies Withdraws April 24 Record Date; Interim Dividend Declaration Deferred
Mold-Tek Technologies has officially withdrawn the record date of April 24, 2026, which was previously established for a proposed interim dividend. This decision follows a Board of Directors meeting on April 20, 2026, where the board opted to defer the declaration of the interim dividend for the financial year 2025-26. Consequently, the anticipated immediate cash return to shareholders is postponed. Investors will need to wait for a future board meeting to reconsider the dividend payout.
Key Highlights
Withdrawal of the previously announced record date of April 24, 2026.
Board of Directors deferred the interim dividend declaration for FY 2025-26 during the April 20 meeting.
The move follows a prior communication dated April 15, 2026, which had originally set the dividend timeline.
No new date for the consideration of the interim dividend has been provided in the current update.
💼 Action for Investors
Investors should monitor upcoming exchange filings for a rescheduled board meeting date to understand the reasons for the deferral and the revised dividend timeline.
Loading analysis...
Mold-Tek Packaging Declares First Interim Dividend of ₹2 Per Share for FY 2025-26
Mold-Tek Packaging Limited has announced its first interim dividend for the financial year 2025-26. The Board of Directors approved a payout of ₹2 per equity share, which translates to 40% of the face value of ₹5. The record date to determine shareholder eligibility has been set for April 24, 2026. This announcement demonstrates the company's consistent policy of rewarding shareholders through periodic payouts.
Key Highlights
First Interim Dividend of ₹2 per equity share declared for FY 2025-26
Dividend payout represents 40% of the face value of ₹5 per share
Record date for dividend eligibility is fixed as April 24, 2026
The dividend will be paid within the stipulated legal timelines
💼 Action for Investors
Investors interested in the dividend should ensure they hold the shares before the ex-dividend date (typically one day prior to the record date). The payout reflects healthy cash flows and a shareholder-friendly management approach.
Loading analysis...
Mold-Tek Packaging Declares Interim Dividend of ₹2 Per Share for FY 2025-26
Mold-Tek Packaging Limited has declared its first interim dividend of ₹2 per equity share for the financial year 2025-26. This dividend represents a 40% payout on the face value of ₹5 per share. The company has established April 24, 2026, as the record date to identify eligible shareholders for this payment. The board meeting was conducted efficiently, concluding within 35 minutes on April 20, 2026.
Key Highlights
Interim dividend of ₹2 per equity share declared for FY 2025-26
Dividend payout represents 40% of the face value of ₹5 per share
Record date for eligibility fixed as Friday, April 24, 2026
Board meeting held on April 20, 2026, between 11:00 A.M. and 11:35 A.M.
💼 Action for Investors
Investors interested in the dividend should ensure they hold the stock before the ex-dividend date to be eligible for the ₹2 per share payout. This announcement reflects the company's commitment to returning value to shareholders.
Loading analysis...
Meghmani Organics Re-appoints 3 Independent Directors for 3-Year Terms
Meghmani Organics Limited (MOL) has received shareholder approval to re-appoint three Independent Directors for a second term of three years, effective May 5, 2026. The appointees include Mr. Manubhai Patel, a finance expert with 45+ years of experience, Prof. (Dr) Ganapati Yadav, a Padma Shri recipient and chemical engineering scientist, and Ms. Urvashi Shah, a legal expert with 21 years of practice. These re-appointments ensure continuity in the board's oversight and strategic guidance until May 4, 2029. The retention of such high-caliber professionals in finance, green chemistry, and law strengthens the company's governance and sustainability framework.
Key Highlights
Re-appointment of 3 Independent Directors for a second term of 3 consecutive years starting May 5, 2026
Mr. Manubhai Patel brings over 45 years of financial management experience, including a tenure as CFO of Zydus Group
Prof. (Dr) Ganapati Yadav, a Padma Shri awardee, contributes expertise with over 570 publications and 140 patents in chemical engineering
Ms. Urvashi Shah provides 21 years of legal expertise in taxation and regulatory compliance
The re-appointments were approved by shareholders via Special Resolutions in accordance with SEBI regulations
💼 Action for Investors
Investors should view this as a positive sign of board stability and strong corporate governance. No immediate action is required as these are planned re-appointments of highly qualified professionals.
Loading analysis...
Mold-Tek Technologies Board to Meet April 20 for Interim Dividend; Record Date April 24
Mold-Tek Technologies has scheduled a board meeting on April 20, 2026, to consider the declaration of the first interim dividend for the financial year 2025-26. The company has pre-emptively fixed April 24, 2026, as the record date to determine shareholder eligibility, contingent on board approval. Furthermore, the trading window for insiders remains closed from April 1, 2026, until 48 hours after the announcement of audited FY26 results. This move indicates a proactive approach to shareholder returns early in the new fiscal year.
Key Highlights
Board meeting scheduled for April 20, 2026, to consider First Interim Dividend for FY 2025-26.
Record date for dividend eligibility fixed as April 24, 2026, subject to board approval.
Trading window remains closed from April 1, 2026, until 48 hours after audited FY26 results are declared.
The announcement follows the conclusion of the financial year ended March 31, 2026.
💼 Action for Investors
Investors should monitor the outcome of the April 20 meeting for the dividend amount. To be eligible for the payout, shares must be purchased before the ex-dividend date, which is typically one working day prior to the April 24 record date.
Loading analysis...
Mold-Tek Packaging Board to Consider Interim Dividend on April 20; Record Date April 24
Mold-Tek Packaging Limited has scheduled a board meeting on April 20, 2026, to consider and declare the first interim dividend for the financial year 2025-26. The company has proactively fixed April 24, 2026, as the record date to determine shareholder eligibility for the potential payout. This announcement comes while the trading window remains closed since April 1, 2026, in anticipation of the audited financial results for the year ended March 31, 2026. Investors should watch for the specific dividend amount to be disclosed following the board's decision.
Key Highlights
Board meeting scheduled for April 20, 2026, to deliberate on the first interim dividend for FY 2025-26.
Record date for dividend eligibility is fixed as Friday, April 24, 2026, contingent on board approval.
Trading window for designated persons has been closed since April 1, 2026, pending audited annual results.
The move signals management's intent to return capital to shareholders early in the new fiscal year.
💼 Action for Investors
Investors seeking dividend income should monitor the April 20 announcement for the quantum of the dividend. To be eligible for the payout, shares must be held in the demat account by the record date of April 24, 2026.
Loading analysis...
Mold-Tek Technologies to Use Rs 4.76 Cr Preferential Issue Proceeds for Nashik Office Construction
Mold-Tek Technologies Limited has clarified the utilization of Rs 4.756 crore raised through a preferential issue of equity shares. The company intends to deploy 100% of these funds toward capital expenditure for a new branch office in Nashik, Maharashtra. This move will transition the Nashik operations from rented premises to a company-owned facility on land acquired in 2023. The project is expected to be completed within 15 to 18 months, supporting long-term business growth and operational stability.
Key Highlights
Total proceeds from the preferential issue aggregate to Rs 4,75,60,000
100% of the funds are allocated for capital expenditure on a new Nashik branch office
The project aims to replace current rented premises with a dedicated facility on land owned since 2023
Estimated timeline for completion is 15 to 18 months from the date of share allotment
💼 Action for Investors
Investors should view this as a positive step toward asset creation and operational efficiency. Monitor the execution timeline of 15-18 months to ensure the expansion stays on track.
Loading analysis...
Meghmani Organics Subsidiary Kilburn Chemicals Rating Outlook Revised to Positive for ₹274 Cr Debt
India Ratings & Research has revised the credit rating outlook for Kilburn Chemicals Limited (KCL), a subsidiary of Meghmani Organics, from 'Negative' to 'Positive' implications. The revision affects bank loan facilities totaling ₹274.2 crore, including a ₹199.2 crore term loan and ₹75 crore in working capital limits. The subsidiary's long-term rating is currently IND BBB, while the short-term rating is IND A3+. This change suggests an improving financial trajectory for the subsidiary, which could eventually lead to lower borrowing costs for the group.
Key Highlights
Rating watch for subsidiary Kilburn Chemicals revised from 'Negative Implications' to 'Positive Implications'.
Total rated bank facilities amount to ₹2,742 million (₹274.2 crore).
Long-term rating maintained at IND BBB and short-term rating at IND A3+.
The facilities include a ₹199.2 crore term loan and a ₹75 crore working capital limit from HDFC Bank.
💼 Action for Investors
This indicates improving creditworthiness of a key subsidiary; investors should monitor for a formal rating upgrade which could signal better operational performance and reduced consolidated interest costs.
Loading analysis...
Mold-Tek Technologies Approves Preferential Issue of Equity Shares at EGM
Mold-Tek Technologies Limited held an Extraordinary General Meeting (EGM) on March 30, 2026, to seek shareholder approval for a preferential issue of equity shares. The meeting, attended by 56 members, focused on this special resolution aimed at raising capital for the company. While specific pricing and allotment details were not disclosed in this summary, the Chairman provided an overview of the strategic intent behind the issue. The final approval depends on the voting results, which will be disclosed separately.
Key Highlights
Special Resolution proposed for the issuance of equity shares on a preferential basis.
The EGM was attended by 56 members via video conferencing on March 30, 2026.
Remote e-voting was conducted between March 26 and March 29, 2026, with a cut-off date of March 23, 2026.
The meeting concluded in 36 minutes after addressing shareholder queries regarding the fundraise.
💼 Action for Investors
Investors should monitor the upcoming disclosure of voting results and specific details regarding the issue price and allottees. This capital infusion is a key indicator of the company's growth or deleveraging plans.
Loading analysis...
Mold-Tek Technologies to Raise Rs 4.76 Crore via Preferential Issue at Rs 164/Share
Mold-Tek Technologies has approved the issuance of 2,90,000 equity shares on a preferential basis to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at Rs 164 each, representing a significant premium over the face value of Rs 2. The total fundraise amounts to approximately Rs 4.76 crore, which will result in the investor holding a 0.997% stake in the company post-allotment. An Extraordinary General Meeting (EGM) is scheduled for March 30, 2026, to seek shareholder approval for the transaction.
Key Highlights
Issuance of up to 2,90,000 equity shares at an issue price of Rs 164 per share.
Total fundraise amount aggregates to Rs 4,75,60,000 from a single non-promoter investor.
The investor, Richard Leon Cannyn, will hold a 0.997% stake in the company post-issue.
Relevant date for pricing as per SEBI ICDR Regulations is February 27, 2026.
Extraordinary General Meeting (EGM) to be held on March 30, 2026, for shareholder approval.
💼 Action for Investors
Investors should note the equity dilution of approximately 1% and monitor how the company intends to utilize these funds for growth. The preferential pricing provides a benchmark for the company's current valuation assessment by external investors.
Loading analysis...
Mold-Tek Technologies to Raise ₹4.76 Crore via Preferential Issue at ₹164 Per Share
Mold-Tek Technologies has approved a preferential allotment of 2,90,000 equity shares to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at ₹164 each, which includes a premium of ₹162, totaling a fundraise of approximately ₹4.76 crore. This issuance will result in the investor holding a 0.997% stake in the company post-allotment. Shareholders will vote on this proposal at an Extraordinary General Meeting (EGM) scheduled for March 30, 2026.
Key Highlights
Issuance of up to 2,90,000 equity shares at a price of ₹164 per share.
Total capital infusion of ₹4,75,60,000 from a single non-promoter investor.
Post-issue, the investor Mr. Richard Leon Cannyn will hold a 0.997% stake in the company.
Extraordinary General Meeting (EGM) convened for March 30, 2026, to seek shareholder approval.
Relevant date for determining the floor price was set as February 27, 2026.
💼 Action for Investors
The fundraise is relatively small but positive as it brings in fresh capital at a premium to face value. Investors should monitor the EGM outcome and the company's plans for utilizing these funds for growth.
Loading analysis...
Mold-Tek Technologies to Raise Rs 4.76 Crore via Preferential Issue at Rs 164/Share
Mold-Tek Technologies has approved the issuance of 2,90,000 equity shares on a preferential basis to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at Rs 164 each, representing a significant premium over the face value of Rs 2. The total fundraise amounts to approximately Rs 4.76 crore, with the investor set to hold a 0.997% stake post-allotment. An Extraordinary General Meeting is scheduled for March 30, 2026, to obtain shareholder approval for this transaction.
Key Highlights
Issuance of 2,90,000 equity shares at a fixed price of Rs 164 per share
Total capital infusion of approximately Rs 4.76 crore from a non-promoter investor
Post-allotment, the identified investor will hold a 0.997% stake in the company
Extraordinary General Meeting (EGM) scheduled for March 30, 2026, for approval
Relevant date for pricing determination set as February 27, 2026
💼 Action for Investors
Investors should view this as a minor positive due to the capital infusion at a premium, though the dilution is minimal at less than 1%. Monitor the EGM outcome and any further disclosures regarding the specific use of these funds for business expansion.
Loading analysis...
Mold-Tek Technologies to Raise ₹4.76 Crore via Preferential Issue at ₹164 per Share
Mold-Tek Technologies' board has approved a preferential allotment of 2,90,000 equity shares to a non-promoter investor, Mr. Richard Leon Cannyn. The shares are priced at ₹164 each, including a premium of ₹162, aggregating to a total fundraise of approximately ₹4.76 crores. This issuance will result in the investor holding a 0.997% stake in the company post-allotment. An Extraordinary General Meeting (EGM) is scheduled for March 30, 2026, to seek shareholder approval for this capital infusion.
Key Highlights
Board approved issuance of 2,90,000 equity shares at a price of ₹164 per share
Total capital to be raised through this preferential allotment is ₹4,75,60,000
The shares are being allotted to a single non-promoter investor, Mr. Richard Leon Cannyn
Post-allotment, the investor will hold a 0.997% stake in the company
Extraordinary General Meeting (EGM) for shareholder approval is set for March 30, 2026
💼 Action for Investors
The fundraise is relatively small in scale but indicates external investor interest; shareholders should monitor the company's plans for utilizing this capital. No immediate action is required as the dilution is minimal at less than 1%.
Loading analysis...
Meghmani Organics Subsidiary Kilburn Chemicals Assigned IND BBB Rating with Negative Watch
India Ratings & Research has assigned credit ratings to Kilburn Chemicals Limited, a subsidiary of Meghmani Organics Limited. The ratings cover bank facilities totaling INR 2,742 million, including a term loan of INR 1,992 million and working capital limits of INR 750 million. Notably, all rated facilities have been placed on 'Rating Watch with Negative Implications,' signaling potential downward pressure on the credit profile. Investors should monitor the subsidiary's operational performance as it may impact the parent company's consolidated financial health.
Key Highlights
India Ratings assigned 'IND BBB' rating to Kilburn Chemicals' INR 1,992 million term loan.
Working capital limits of INR 750 million received 'IND BBB' and 'IND A3+' ratings.
Total rated bank facilities for the subsidiary amount to INR 2,742 million.
All facilities are placed on 'Rating Watch with Negative Implications' as of February 27, 2026.
💼 Action for Investors
Investors should monitor the reasons behind the 'Negative Implications' watch, as a potential downgrade could increase borrowing costs for the subsidiary and affect the parent company's valuation.
Loading analysis...
Mold-Tek Technologies Q3 Profits Surge 6x YoY; Targets $25M Revenue in FY27
Mold-Tek Technologies reported a stellar Q3 FY26 with profits growing over sixfold year-on-year and 20.2% sequentially. The company is aggressively restructuring its underperforming automotive division, reducing headcount from 160 to 60 to focus on high-growth areas like transmission poles and data centers. Management has set a revenue target of $25 million (approx. INR 225-230 crores) for next year, driven by the integration of the Beryl acquisition and offshoring benefits. The company aims for a 20-25% CAGR over the next 3-5 years through organic growth and further strategic acquisitions.
Key Highlights
Q3 FY26 profits increased by more than 6x YoY and 20.2% on a QoQ basis.
Revenue guidance for FY27 set at $25 million, representing a significant jump from the estimated INR 180 crores in FY26.
Beryl acquisition contributed $137,000 (INR 1.25 crores) in operating profit during its first two months of operations.
Mechanical Engineering (MES) division is being downsized from 160 to 60 members to eliminate losses and improve efficiency.
Data center projects are expected to contribute $2.5 million to $3.5 million in incremental annual revenue across civil and mechanical segments.
💼 Action for Investors
Investors should view the aggressive cost-cutting in the automotive segment and the successful integration of Beryl as strong catalysts for margin expansion. Monitor the company's ability to transition Beryl's high-cost US operations to its Indian back-office to realize projected profitability gains.
Loading analysis...
Mold-Tek Packaging Q3 FY26: EBITDA Up 14%, Targets ₹1,000 Cr Revenue in FY27
Mold-Tek Packaging reported a 14% YoY EBITDA growth in Q3 FY26, despite the quarter being seasonally weak. The company is consolidating its Hyderabad operations from five units into two to enhance operational efficiency and cost control, with benefits expected from next quarter. Management has set an ambitious revenue target of over ₹1,000 crore for FY27, driven by a 12-15% volume growth outlook. The Pharma segment remains a key growth lever, with a target of ₹50-55 crore for the next fiscal year.
Key Highlights
9M FY26 EBITDA grew by 20% YoY, while Q3 volumes increased by 6%.
Revised FY26 volume guidance to 42,500 tons (11% growth) due to extended monsoons.
Pharma segment on track for ₹35 crore in FY26 with 25+ clients cleared for production.
Manufacturing consolidation in Hyderabad to be completed by March 2026 to improve margins.
Projected FY26 PAT of ₹73-75 crore, representing a 20% year-on-year growth.
💼 Action for Investors
Investors should focus on the company's transition into high-margin Pharma packaging and the efficiency gains from plant consolidation. The ₹1,000 crore revenue guidance for FY27 suggests strong management confidence in volume recovery.
Loading analysis...
Anmol India Q3 Net Profit Surges to ₹2.94 Cr from ₹0.38 Cr YoY; Revenue Up 20%
Anmol India Limited reported a strong performance for the quarter ended December 31, 2025, with revenue from operations reaching ₹303.16 crore, a 19.7% increase compared to ₹253.32 crore in the same quarter last year. The net profit saw a massive surge to ₹2.94 crore from just ₹0.38 crore in Q3 FY25, indicating a significant improvement in margins. On a nine-month basis, the company's PAT grew to ₹8.79 crore from ₹5.39 crore in the previous year. The basic EPS for the quarter improved significantly to ₹0.52 from ₹0.07 YoY.
Key Highlights
Revenue from operations grew 19.7% YoY to ₹303.16 crore in Q3 FY26.
Net profit (PAT) surged by over 670% YoY to ₹2.94 crore from ₹0.38 crore.
Profit Before Tax (PBT) increased to ₹3.93 crore compared to ₹0.51 crore in the year-ago period.
Nine-month (9M FY26) revenue stood at ₹1,108.06 crore, up from ₹960.03 crore in 9M FY25.
Basic EPS for the quarter rose to ₹0.52 from ₹0.01 in the preceding quarter (Q2 FY26).
💼 Action for Investors
Investors should monitor if the company can sustain these improved margins in the coming quarters, as the sharp turnaround in profitability is a strong positive signal. The stock may see positive momentum given the significant growth in both top-line and bottom-line figures.
Loading analysis...
Mold-Tek Technologies Q3 Net Profit Jumps to ₹3.89 Cr; Revenue Up 57% YoY
Mold-Tek Technologies reported a robust consolidated performance for Q3 FY26, with revenue from operations rising 56.7% YoY to ₹5,266.70 lakhs. Net profit for the quarter saw a significant recovery, reaching ₹388.85 lakhs compared to ₹54.19 lakhs in the same period last year. Despite the strong quarterly surge, the nine-month PAT of ₹780.84 lakhs still trails behind the ₹1,372.83 lakhs earned in the previous year's corresponding period. The company's US-based engineering subsidiaries remain a core driver of its consolidated financial structure.
Key Highlights
Consolidated Revenue from operations increased 56.7% YoY to ₹5,266.70 lakhs.
Net Profit (PAT) for Q3 FY26 surged to ₹388.85 lakhs from ₹54.19 lakhs in Q3 FY25.
Earnings Per Share (EPS) for the quarter improved to ₹1.35 from ₹0.19 YoY.
Employee benefit expenses remain the largest cost factor, accounting for ₹3,758.74 lakhs in Q3.
Nine-month consolidated revenue grew to ₹12,618.92 lakhs, though 9M PAT remains 43% lower than the previous year.
💼 Action for Investors
The sharp recovery in Q3 margins and profitability suggests a positive turnaround in business momentum. Investors should watch if this growth trajectory continues in Q4 to fully offset the weaker performance seen earlier in the fiscal year.
Loading analysis...
Mold-Tek Packaging 9M FY26 EBITDA Up 20% to ₹125.55 Cr; Pharma Volume Surges 190%
Mold-Tek Packaging reported a 12% YoY revenue growth to ₹648.75 crore for 9M FY26, while PAT rose 18% to ₹52.23 crore. The company demonstrated strong operational efficiency with EBITDA margins expanding to 19.35% and EBITDA per kg rising 10% to ₹40.24. The Pharma vertical is emerging as a high-growth driver, recording a 190% volume jump in Q3 FY26. Furthermore, a new MoU for UK-based high-precision closures offers a ₹250 crore revenue opportunity over five years.
Key Highlights
9M FY26 EBITDA grew 20% YoY to ₹125.55 crore with margins improving by 125 bps to 19.35%
Pharma segment Q3 volume grew 190% YoY, contributing ₹10.81 crore in quarterly sales
Strategic MoU with Vibe Generation Holdings (UK) targets ₹250 crore revenue over 5 years
9M FY26 Sales Volume reached 31,203 MT, a 9% increase over the previous year
EBITDA per KG increased from ₹36.73 to ₹40.24, indicating a shift towards high-value products
💼 Action for Investors
Investors should view the margin expansion and rapid Pharma growth as strong indicators of successful business diversification. The stock remains a quality play on rigid packaging with significant upside potential from the new international partnership.